Literature DB >> 21703344

Distribution of vascular endothelial growth factor receptor-3/Flt4 mRNA in adult rat central nervous system.

Yun Hou1, Yoo-Jin Shin, Esther Jiwon Han, Jeong-Sun Choi, Jang-Mi Park, Jung-Ho Cha, Jae-Youn Choi, Mun-Yong Lee.   

Abstract

Vascular endothelial growth factor receptor (VEGFR)-3/Flt4 binds VEGF-C and VEGF-D with high affinity. It has been suggested to be involved in neurogenesis and adult neuronal function. However, little is known about the localization of VEGFR-3 in the adult central nervous system (CNS). The present study presents, to our knowledge, the first detailed mapping of VEGFR-3 mRNA expression in adult rat brain and spinal cord by using in situ hybridization and reverse transcription-polymerase chain reaction analysis (RT-PCR). Varying VEGFR-3 expression intensity was detected in functionally diverse nuclei, with the highest levels in the mitral cells of the olfactory bulb, piriform cortex, anterodorsal thalamic nucleus, several nuclei of the hypothalamus, and the brainstem cranial nerve nuclei. VEGFR-3 mRNA was abundantly expressed in the ventral motor neurons of the spinal cord and in some circumventricular organs such as the median eminence and the area postrema. Moreover, the locus coeruleus and some of the nuclei of the reticular formation showed moderate-to-high hybridization signals. VEGFR-3 expression appeared to be localized mostly within neurons, but weak labeling was also found in some astrocytes. In particular, VEGFR-3 was highly expressed in ependymal cells of the ventral third ventricle and the median eminence, which were co-labeled with vimentin but not with glial fibrillary acidic protein, suggesting that these cells are tanycytes. RT-PCR analysis revealed similar levels of VEGFR-3 expression in all regions of the adult rat CNS. The specific but widespread distribution of VEGFR-3 mRNA in the adult rat CNS suggests that VEGFR-3 functions more broadly than expected, regulating adult neuronal function playing important roles in tanycyte function.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703344     DOI: 10.1016/j.jchemneu.2011.06.001

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  5 in total

Review 1.  Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells.

Authors:  Jean-Leon Thomas; Kasey Baker; Jinah Han; Charles Calvo; Harri Nurmi; Anne C Eichmann; Kari Alitalo
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

2.  Vascular endothelial growth factor receptor 3 controls neural stem cell activation in mice and humans.

Authors:  Jinah Han; Charles-Félix Calvo; Tae Hyuk Kang; Kasey L Baker; June-Hee Park; Carlos Parras; Marine Levittas; Ulrick Birba; Laurence Pibouin-Fragner; Pascal Fragner; Kaya Bilguvar; Ronald S Duman; Harri Nurmi; Kari Alitalo; Anne C Eichmann; Jean-Léon Thomas
Journal:  Cell Rep       Date:  2015-02-19       Impact factor: 9.423

3.  Germline Mutation Enrichment in Pathways Controlling Endothelial Cell Homeostasis in Patients with Brain Arteriovenous Malformation: Implication for Molecular Diagnosis.

Authors:  Concetta Scimone; Francesca Granata; Marcello Longo; Enricomaria Mormina; Cristina Turiaco; Antonio A Caragliano; Luigi Donato; Antonina Sidoti; Rosalia D'Angelo
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

4.  Characterisation of endogenous players in fibroblast growth factor-regulated functions of hypothalamic tanycytes and energy-balance nuclei.

Authors:  Benediktas Kaminskas; Timothy Goodman; Andrew Hagan; Saverio Bellusci; David M Ornitz; Mohammad K Hajihosseini
Journal:  J Neuroendocrinol       Date:  2019-07-08       Impact factor: 3.627

5.  Increased expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 after pilocarpine-induced status epilepticus in mice.

Authors:  Kyung-Ok Cho; Joo Youn Kim; Kyoung Hoon Jeong; Mun-Yong Lee; Seong Yun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2019-06-25       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.